SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Disclose 6.7% Stake in Sage Therapeutics
Beneficial Ownership Report
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting a beneficial ownership of 6.7% of Sage Therapeutics Inc.'s common stock as of December 31, 2024.
Summary
- FMR LLC and Abigail P. Johnson have filed an Amendment No. 15 to Schedule 13G regarding their beneficial ownership in SAGE THERAPEUTICS INC.
- As of December 31, 2024, the reporting persons beneficially own an aggregate of 4,117,005.58 shares of SAGE THERAPEUTICS INC's common stock.
- This represents 6.7% of the total outstanding common stock of SAGE THERAPEUTICS INC.
- FMR LLC holds sole voting power over 4,115,436.00 shares and sole dispositive power over 4,117,005.58 shares.
- Abigail P. Johnson, as an individual, holds sole dispositive power over 4,117,005.58 shares.
- The filing indicates that FMR LLC is a parent holding company, and its subsidiaries involved include Fidelity Management & Research Company LLC (Investment Adviser), Fidelity Management Trust Company (Bank), and Strategic Advisers LLC (Investment Adviser).
- The securities were acquired and are held in the ordinary course of business and were not acquired or held for the purpose of or with the effect of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The document is a factual report of beneficial ownership and does not contain information that would indicate a positive or negative sentiment regarding the issuer's performance or outlook.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: The filing indicates a significant institutional investor, FMR LLC, holds a 6.7% stake, which may be viewed as a vote of confidence in Sage Therapeutics Inc.
Key Dates
| Date | Description |
|---|---|
| January 3, 2023 | Effective date of Power of Attorney for FMR LLC. |
| January 26, 2023 | Effective date of Power of Attorney for Abigail P. Johnson. |
| December 31, 2024 | Date of event which requires filing of this statement (ownership determination date). |
| February 11, 2025 | Date of signing/filing of the Schedule 13G Amendment. |
Keywords
Sage Therapeutics Inc, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.